Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo

Basic Research in Cardiology

Volumn 103, Issue 4, 2008, Pages 356-367

  Schulz, Christian ^a   Penz, Sandra ^b   Hoffmann, Christof ^a   Langer, Harald ^c   Gillitzer, Angelika ^c   Schneider, Simon ^a   Brandl, Richard ^d   Seidl, Stefan ^a   Massberg, Steffen ^a   Pichler, Bernd ^b   Kremmer, Elisabeth ^e   Stellos, Konstantinos ^c   Schönberger, Tanja ^c   Siess, Wolfgang ^b   Gawaz, Meinrad ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Klinikum Schwabing   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Atherosclerosis; Carotid arteries; Collagen; Imaging; Platelets

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FC RECEPTOR; GLYCOPROTEIN VI; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; PROTEIN FUNCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 46149119865     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-008-0722-3     Document Type: Article

References (29)

1. Alevriadou BR, McIntire LV (1995) Rheology. Loscalzo J, Schafer AI (eds) Thrombosis and hemorrhage. Blackwell, Cambridge, pp 369-384
2. Brandl R, Richter T, Haug K, Wilhelm MG, Maurer PC, Nathrath W (1997) Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation 96:3360-3368
3. Cabeza N, Li Z, Schulz C, Kremmer E, Massberg S, Bultmann A, Gawaz M (2004) Surface expression of collagen receptor Fc receptor-gamma/ glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53:2117-2121
4. Coller BS, Beer JH, Scudder LE, Steinberg MH (1989) Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 74:182-192
5. Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW (2005) Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 181:19-27
6. De Meyer GR, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, Bult H (1999) Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol 19:2524-2534
7. Dietrich T, Perlitz C, Licha K, Stawowy P, Atrott K, Tachezy M, Meyborg H, Stocker C, Gräfe M, Fleck E, Schirner M, Graf K (2007) ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions. Basic Res Cardiol 102:298-307
8. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG (2004) The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2:561-573
9. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562-1569
10. Gawaz M (2004) Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 61:498-511
11. Gawaz M, Konrad I, Hauser AI, Sauer S, Li Z, Wester HJ, Bengel FM, Schwaiger M, Schomig A, Massberg S, Haubner R (2005) Non-invasive imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost 93:910-913
12. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378-3384
13. Guyton JR, Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16:4-11
14. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61-67
15. Katsuda S, Kaji T (2003) Atherosclerosis and extracellular matrix. J Atheroscler Thromb 10:267-274
16. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887-896
17. Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41-49
18. Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, Peluso M, Lorenz M, Schneider S, Besta F, Muller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397-399
19. Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, Kremmer E, Emambokus NR, Frampton J, Gawaz M (2005) Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112:1180-1188
20. Moroi M, Jung SM (2004) Platelet glycoprotein VI: Its structure and function. Thromb Res 114:221-233
21. Nieswandt B, Watson SP (2003) Platelet-collagen interaction: Is GPVI the central receptor? Blood 102:449-461
22. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W (2005) Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 19:898-909
23. Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W (2003) Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 108:741-747
24. Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227-1234
25. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96:6931-6936
26. Theilmeier G, Michiels C, Spaepen E, Vreys I, Collen D, Vermylen J, Hoylaerts MF (2002) Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 99:4486-4493
27. Von Hundelshausen P, Weber C (2007) Platelets as Immune Cells. Bridging inflammation and cardiovascular disease. Circ Res 100:27-40
28. Weidtmann A, Scheithe R, Hrboticky N, Pietsch A, Lorenz R, Siess W (1995) Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arterioscler Thromb Vasc Biol 15:1131-1138
29. Zernecke A, Weber C (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100:93-101